https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
We assessed frontal executive functions in patients with RLS/WED with and without augmentation and compared the results to healthy controls. We recruited 38 patients with RLS/WED. A total of 23 patients were treated with dopaminergic therapy and showed no signs of augmentation and 15 patients had a history of augmentation (AUG). Results were compared to 21 healthy controls. All individuals were assessed by the Frontal Assessment Battery (FA and the MMSE. Furthermore, impulsivity was assessed during a semi-structured
Like
Comment
Share
